Why has ResMed rocketed up and is the ride over?
In our latest podcast episode, discover insights on ResMed's stock analysis and the impact of Ozempic and GLP-1 drugs with Senior Equity...
Small cap M&A likely to continue driving returns this year
Towards the end of 2023 there was a significant increase...
Update on reporting season and performance of IML’s large cap portfolios
One of my favourite quotes about investing is from the...
Back in health – small cap healthcare stocks looking good for 2024
The IML small and mid cap team are excited about...
THE DIFFERENCE BETWEEN SPECULATING AND INVESTING
Most people would feel that they understand the difference between...